Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomes
Xin L Tan, David K Wright, Shijie Liu, Christopher Hovens, Terence J O'Brien, Sandy R Shultz
Neuropharmacology | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2016
Awarded by NHMRC
This study was funded by a grant to SRS from the NHMRC (#1062653), and fellowships to SRS from the Canadian Institute of Health Research and the NHMRC. The authors declare that there are no competing financial interests in relation to this work.